Publications by authors named "M Roussel"

Claim this Profile
P
Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial).
N Alshatti, F Lemonnier, E Bachy, J Lopez, F Llamas, M Roussel

Immunooncol Technol· March 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?
Marta Canelo-Vilaseca, Mohamad Sabbah, Caterina Cristinelli, Bommier Côme, Pierre Sesques, Mikael Roussel

Bone Marrow Transplant· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal-related neuropathies: diagnosis, prognosis, and outcomes.
Arnaud Jaccard, Laurent Magy, Bertrand Arnulf, Frank Bridoux, Murielle Roussel

Hematology Am Soc Hematol Educ Program· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Feasibility of carfilzomib infusions in hospital at home for patients with multiple myeloma (the Carfil-HAD study)].
Mohamed Touati, Camille Villesuzanne, Gaëlle Maillan, Natalia Dmytruk, Caroline Streicher, Murielle Roussel

Bull Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hidden-driver inference reveals synergistic brain-penetrant therapies for medulloblastoma.
Jingjing Liu, Xu Yang, Mingrui Zhu, Xinran Dong, Honglei Zhou, Martine F Roussel

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis